1.3. Analysis.
Comparison 1 Topiramate vs placebo as monotherapy, Outcome 3 Acceptability with topiramate as monotherapy. Number of participants experiencing troublesome side effects of any nature (endpoint: 12 weeks).
Comparison 1 Topiramate vs placebo as monotherapy, Outcome 3 Acceptability with topiramate as monotherapy. Number of participants experiencing troublesome side effects of any nature (endpoint: 12 weeks).